Products
Platform
Research
Market
Learn
Partner
Support
IPO

P

Privi Speciality Chemicals Share Price

2616.1
-53.70 (-2.01%)
PRIVISCL • 19 Jan, 2026 | 02:59 PM
Buywith MTF at 2.86x leverage

1Y Annualised Return

42.04%

3Y Annualised Return

35.00%

5Y Annualised Return

33.73%

10Y Annualised Return

31.80%

The current prices are delayed, login or Open Demat Account for live prices.

Privi Speciality Chemicals Stock Performance

1W Return-3.55
1Y Return40.89
Today's Low2605
Prev. Close2,669.80
Mkt Cap (Cr.)10,219.19
1M Return-15.29
3Y Return141.55
52-Week High3440.5
Open2,653.00
PE Ratio36.58
6M Return6.77
Today's High2669.7
52-Week Low1368.15
Face Value10

Privi Speciality Chemicals Company background

Founded in: 1985
Managing director: Mahesh Babani
Privi Speciality Chemicals Limited is Indias leading manufacturer, supplier, and exporter of aroma and fragrance chemicals and a globally trusted partner and supplier of bulk aroma chemicals. The Company has inhouse integrated manufacturing facilities situated at Mahad in Maharashtra and Jhagadia in Gujarat with knowledge, expertise and capacity to perform critical reactions like Hydrogenation, Condensation, Grignard reactions, as well as unit operations like Pyrolysis, Reactive Distillation, High Vacuum Distillation, Continuous Distillation to deliver consistency. Privi Speciality Chemicals Limited was initially incorporated as Fairchem Speciality Limited on May 25, 1985. The Company changed the name from Fairchem Speciality Limited to Privi Speciality Chemicals Limited on October 14, 2020. It started manufacturing aroma chemicals in year 1992 with only two products, which it gradually expanded to a range of over 50 products as of today, having a capacity of over 32,500 tons per annum. It develops and produces custommade aroma chemicals as per specific requirement of the customers.The company came out with a public issue in Feb.95 to set up facilities at Sanand, near Ahmedabad, to manufacture 3248 tpa of distilled fatty acids like oleic acid, linoleic acid and palmitic acid 2894 tpa of rice bran oil grade1 and 625 tpa of monoglycerides. Company has made private placement in 199697, having paid up equity from 7.00 Crores to 8.50 CroresThe company has a technical collaboration with UIC, US. Equipment were procured from Sulzer, Switzerland Feld Hahn, Germany and UIC, US. During the year 199697, the second phase of Short Path Distillation Plant commenced its commercial production in the month of Nov96. Company has export his main product viz.Deodorizer Distillate (Mixed Tocopherols) to Henkel Corporation who has buy entire production of this product. Company has placed the orders for putting up continuous fat splitting plant, which helps the company to upgrading the second stream of by product vizResidual Oil by converting into split Fatty Acid, which can be upgraded by further processing in Fractionation plant increased value of domestic sales. During 19992000, the company has successfully commissioned Fat Splitting Plant to increase the availiability of high value fatty acids for sale in domestic market.In 2001, Company started making Dimer Acid and Monobasic Acid by using one of its finished product streams.During year 2004, Company enhanced its annual raw material throughput capacity to 6,000 MT. In year 2006, it carried out laboratory trials of further concentration of Tocopherols.In 2011, it focused more on reduction of manufacturing cost per ton. It went through a complete reengineering of its Energy Consumption System and Installation of new balancing equipments. The raw material throughput capacity was increased from 8,000 M.Tons to 12,000 M.Tons during the year.In 2013, the Company increased manufacturing capacity further to 18,000 MTPA. In 2014, Company increased its installed capacity to 24,000 MTPA and undertook CAPEX to increase this capacity to 45,000 MT p.a.In 2015, it further increased installed capacity to 45,000 MTPA. The Canada based Fairfax Group signed a Share Purchase Agreement with existing (Indian) Promoters and acquired 45% equity stake in the Company, which completed in February, 2016. During Q3 of year 2015, Company commissioned new High Pressure Fat Splitting Plant and a new Fractionation column was commissioned.During the year 2016, Company commissioned its new Dimerization plant. In August, 2016, Fairfax acquired 51% equity stake in Privi Organics Limited whose business of Aroma Chemicals is now vested in the Companys wholly owned subsidiary company as per Scheme of Arrangement. Pursuant to Order of NCLT dated 30 June 2020, a Composite Scheme of Arrangement and Amalgamation was approved amongst Fairchem Speciality Limited (Demerged/Transferee Company), Fairchem Organics Limited (Resulting Company) and Privi Organics India Limited (Transferor Company) and their respective Shareholders, through which business of Privi Organics India Limited (POIL) merged into Fairchem Speciality Limited (FSL). Therefore, the business activities of the Company (FSL) has been demerged/transferred to FOL. In 2022, Company signed a Joint Venture Agreement with Givaudan SA, a Company incorporated in Switzerland, for manufacturing highly specialized aroma Chemicals for Givaudan and a new Subsidiary, Prigiv Specialties Private Limited incorporated on September 01, 2021.The Company launched Galaxmusk, Camphor and Prionyl as newly products to increase the market share in 2023. In 202324, the commercial production of 2 new products, Indomarone and Floravone at Unit VI, in Bharuch district of Gujarat commenced in December 2023. In FY 202425, Company launched 3 new products, including Florovane, Indomerane, Amber Woody Xtreme. It started commercial production at PRIGIV (JV with Givaudan). It established a Greenfield Facility in Mahad district of Maharashtra on October 4, 2024, making the plant operational in February, 2025.

Privi Speciality Chemicals Financial Highlights


For the full year FY2025–2026, revenue reached ₹2121.84 crore and profit touched at ₹184.75 crore. As of Dec '25, Privi Speciality Chemicals’s market capitalisation stood at ₹10,219.19 crores. Shareholding as of Dec '25 shows promoters holding 60.6%, with FIIs at 1.6%, DIIs at 10.3%, and public at 27.5%.

Privi Speciality Chemicals Share Price Today


As of 19 Jan 2026, Privi Speciality Chemicals share price is ₹2616.1. The stock opened at ₹2653 and had closed at ₹2669.8 the previous day. During today’s trading session, Privi Speciality Chemicals share price moved between ₹2,605.00 and ₹2,669.70, with an average price for the day of ₹2637.35. Over the last 52 weeks, the stock has recorded a low of ₹1,368.15 and a high of ₹3,440.50. In terms of performance, Privi Speciality Chemicals share price has increased by 6.8% over the past six months and has increased by 42.04% over the last year.
Read More
Privi Speciality Chemicals SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Privi Speciality Chemicals Fundamental

Market Cap (in crs)

10,219.19

Face Value

10

Turnover (in lacs)

1,955.04

Key Metrics

Qtr Change %
91.21% Gain from 52W Low
-3.6
Dividend yield 1yr %
Low in industry
0.2

Privi Speciality Chemicals Key Financials

View more
Loading chart...
Privi Speciality Chemicals Quarterly Revenue
Privi Speciality Chemicals Yearly Revenue
Privi Speciality Chemicals Quarterly Net Profit/Loss
Privi Speciality Chemicals Yearly Net Profit/Loss

Privi Speciality Chemicals Result Highlights

  • Privi Speciality Chemicals Ltd reported a 19.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 26.3%.

  • Its expenses for the quarter were up by 13.8% QoQ and 16.2% YoY.

  • The net profit increased 56.8% QoQ and increased 101.2% YoY.

  • The earnings per share (EPS) of Privi Speciality Chemicals Ltd stood at 24.04 during Q2 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Privi Speciality Chemicals Shareholding Pattern

Promoter
60.6%
Foreign Institutions
1.6%
Mutual Funds
9.6%
Domestic Institutions
10.3%
Public
27.5%

Privi Speciality Chemicals Technical Analysis

Moving Averages Analysis
2616.1
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Day EMA5
2,670.20
Day EMA10
2,724.30
Day EMA12
2,747.60
Day EMA20
2,826.80
Day EMA26
2,867.00
Day EMA50
2,911.10
Day EMA100
2,811.30
Day EMA200
2,557.80
Delivery & Volume
Loading chart...

Day

56.40%

Week

53.80%

Month

59.60%

Delivery & Volume

2,630.27
Pivot
Resistance
First Resistance
2,655.53
Second Resistance
2,694.97
Third Resistance
2,720.23
Support
First Support
2,590.83
Second support
2,565.57
Third Support
2,526.13
Relative Strength Index
32.91
Money Flow Index
6.80
MACD
-119.40
MACD Signal
-98.84
Average True Range
105.67
Average Directional Index
31.72
Rate of Change (21)
-13.30
Rate of Change (125)
8.85
Compare

Privi Speciality Chemicals Latest News

06 JAN 2026 | Tuesday
02 JAN 2026 | Friday
01 JAN 2026 | Thursday

Please be aware that Privi Speciality Chemicals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account